Market Trends of Global Electrophysiology Industry
Ablation Catheters Segment is Expected to Hold Significant Market Share Over the Forecast Period
One form of heart ablation therapy used to treat irregular heart rhythms is catheter ablation. Ablation is a method for carefully removing aberrant tissue to restore normal heart function. Ablation catheters are helpful in removing anomalous heart tissues that may result in irregular heartbeats. Ablation catheters function through ablation, a minimally invasive procedure that directs catheters to destroy defective electrical pathways in the heart.
Factors such as increased technological advancements, research and development in the field of ablation catheters, and a rise in cardiac complications are boosting the market growth. For instance, a study published in Cureus Journal in August 2023 indicates that catheter ablation (CA) is used as a rhythm control strategy to restore normal rhythm in managing atrial fibrillation. Patients who underwent ablation reported significant improvements in their quality of life. Therefore, the advantages of cardiac ablation and the high prevalence of cardiac arrest in developed nations are anticipated to drive market growth.
Furthermore, the market players are adopting various strategies such as collaborations, partnerships, product launches, regulatory approvals, acquisitions, and expansions to increase market share. For instance, in May 2023, the United States Food and Drug Administration (FDA) has approved the Abbott's sensor enabled TactiFlex ablation catheter. This ablation catheter features a flexible tip and contact force technology intended for ablation procedures to treat atrial fibrillation (AFib). Therefore, such approvals facilitate the increased adoption of ablation catheters as they offer reduced procedure times and improved safety.
Hence, owing to the above-mentioned factors such as high prevalence of cardiac arrests, various advantages of cardiac ablations, and key initiatives adopted by the market players, the ablation catheter segment is expected to grow over the forecast period.
North America Holds a Significant Market Share and Expected to do Same in the Forecast Period
The North America region holds a significant market share of the electrophysiology market. It is expected to maintain its stronghold due to the presence of well-established healthcare facilities, technological advancements, an increase in the number of arrhythmia and heart failure cases, and the presence of key market players in the region.
The high prevalence of myocardial infarction in the United States is anticipated to increase the adoption of electrophysiology, driving market growth. For instance, according to the United States National Center for Health Statistics data published in 2024, the percentage of heart attacks for adults aged 18 and over in the United States was 3% in 2023. Such a huge incidence is anticipated to increase the adoption of electrophysiology to study the electrophysiological (EP) substrate of human ventricles after myocardial infarction.
Product launches and approvals, technical advancements, and key players in the field of electrophysiology fuel the market growth. For instance, in August 2023, the United States Food and Drugs Administration approved several products in the cardiac ablation portfolio developed by Biosense Webster, Inc. such as the THERMO COOL SMARTTOUCH SF catheter, which is majorly used ablation catheter for radiofrequency ablation. Such launches helps in increased adoption of advanced products for the effective treatment of arrhythmias, boosting the market growth.
Hence, owing to the above-mentioned factors such as high prevalence of myocardial infarction, key strategies adopted by the market players, the market for electrophysiology in North America is expected to drive the over the forecast period.
